act Bacteria Tag Team Tumors with T Cells By www.medgadget.com Published On :: Tue, 31 Oct 2023 17:07:11 +0000 A team at Columbia University School of Engineering and Applied Science has developed a technique to enhance chimeric antigen receptor (CAR) T cell therapy in solid tumors. The technique involves engineering E. coli bacteria, that naturally tend to accumulate in the immune privileged core of solid tumors. The bacteria have been engineered to interact with […] Full Article News CAR T columbia columbiauniversity
act Best Practices for Successfully Transitioning a Patient Services Hub By feeds.feedblitz.com Published On :: Fri, 20 Sep 2024 10:30:00 +0000 Today’s guest post comes from Josh Marsh, Vice President and General Manager, Sonexus™ Access and Patient Support at Cardinal Health Josh discusses challenges manufacturers may face when outsourcing patient support programs. He outlines a process that smoothly transitions hubs and minimizes disruptions for patients and healthcare providers. To learn more, download the 3-step guide to patient hub transitions. Read on for Josh’s insights. Read more » Full Article Guest Post Sponsored Post
act Hospitals Are Relying More on PBMs to Manage Manufacturers' 340B Contract Pharmacy Restrictions: DCI's 2024 Market Analysis (rerun) By feeds.feedblitz.com Published On :: Wed, 02 Oct 2024 10:30:00 +0000 This week, I’m rerunning some popular posts while we put the finishing touches on DCI’s new 2024-25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. Click here to see the original post from June 2024. The 340B contract pharmacy market shows little sign of slowing down. Drug Channels Institute’s exclusive analysis of the 2024 market reveals that:About 33,000 pharmacy locations—more than half of the entire U.S. pharmacy industry—act as contract pharmacies for the hospitals and federal grantees that participate in the 340B program. Five multi-billion-dollar, for-profit, publicly traded pharmacy chains and pharmacy benefit managers (PBMs)—Cigna (via Express Scripts), CVS Health, UnitedHealth Group (via OptumRx), and Walgreens, Walmart—continue to dominate the 340B contract pharmacy market.Federal grantees are aligned primarily with the vertically intergated organizations' retail pharmacies, while hospitals rely on mail and specialty pharmacies.Over the past four years, manufacturers’ restrictions on 340B contract pharmacies have led hospitals to deepen their relationships with the largest PBMs—even as those PBMs have simultaneously limited hospitals’ direct participation in specialty pharmacy networks. For an updated look at what’s next for the 340B contract pharmacy market, join Adam J. Fein, Ph.D., on June 21 for his latest live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook. Read more » Full Article 340B Channel Management Hospitals Inflation Reduction Act of 2022 Pharmacy Specialty Drugs
act Informa Connect’s PBM Contracting Summit By feeds.feedblitz.com Published On :: Mon, 07 Oct 2024 10:30:00 +0000 Informa Connect’s PBM Contracting Summit December 10-11, 2024 | Chicago, IL Drug Channels readers save 10% with code 24DRCH10* Experts from across the US come together each year at the PBM Contracting Summit to gain innovative and practical contracting strategies, master PBM innovation and design, improve patient care management and rising costs, understand the current legislative issues impacting contract negotiations and more. Join us in Chicago (or virtually) where you’ll benefit from two days of learning, education and networking, and will return to the office having mastered the complex PBM landscape. You’ll hear from Matthew Gibbs, Pharm.D., Pharmacy Transformation Leader of Blue Shield of California as he leads a comprehensive discussion on the PBM landscape over the last year, and delves into the evolving trends and emerging challenges shaping the current industry today. Other expert and thought leaders from within the industry are slated to present deep dive sessions, workshops and panels that will answer your most pressing questions: What are the latest legislative updates and proposed federal bills impacting PBM operations? What's on the horizon for alternative PBMs? What are the top intricacies of rebate eligibility? What are the market impacts of innovative models such as Mark Cuban's Cost Plus Drugs and Amazon's pharmacy model? What can be learned from the J&J lawsuit? Review the expansion of data access and the importance of employer's fiduciary duties. What are the challenges of vertical integration? How do PBMs manage their contracting processes with plan sponsors to create successful contracts? What are the most effective strategies for spread pricing and reimbursement models? What is the best solution to navigate the challenges of the 340B drug pricing program and PBM contracting? What is the best way to design and optimize benefits for covering GLP-1s? How can I ensure compliance with ERISA requirements? What are the latest developments in copay maximizer and accumulator programs? What market dynamics and barriers are impacting pricing and demand? What can be learned from the economic landscape of biosimilars and specialty therapeutics? And much more! View the agenda for the PBM Contracting Summit to see the complete picture – the program, speakers, and more, visit www.informaconnect.com/pbm-contracting for further details and to register. Drug Channels readers will save 10% off when they use code 24DRCH10 and register prior to November 8, 2024.* *Cannot be combined with other offers or used towards a current registration. Cannot be combined with special category rates or other offers. Other restrictions may apply. The content of Sponsored Posts does not necessarily reflect the views of HMP Omnimedia, LLC, Drug Channels Institute, its parent company, or any of its employees. To find out how you can promote an event on Drug Channels, please contact Paula Fein (paula@DrugChannels.net). Full Article Sponsored Post
act The 340B Program Reached $66 Billion in 2023—Up 23% vs. 2022: Analyzing the Numbers and HRSA’s Curious Actions By feeds.feedblitz.com Published On :: Tue, 22 Oct 2024 10:30:00 +0000 Reality has again failed to support the spin surrounding the 340B Drug Pricing Program. For 2023, discounted purchases under the 340B program reached a record $66.3 billion—an astounding $12.6 billion (+23.4%) higher than its 2022 counterpart. The gross-to-net difference between list prices and discounted 340B purchases also grew, to $57.8 billion (+$5.5 billion). 340B purchases are now almost 40% larger than Medicaid’s prescription drug purchases. Hospitals again accounted for 87% of 340B purchases for 2023. Purchases at every 340B covered entity type grew, despite drug prices that grew more slowly than overall inflation. Lobbyists claim that manufacturers’ 340B contract pharmacy changes are “stripping billions of dollars from the healthcare safety net.” But every year, the data tell a very different story. Only in the U.S. healthcare system can billions more in payments and spreads be considered a cut. Read on for full details and our analysis, along with fresh details of troubling behavior by the Health Resources and Services Administration (HRSA). Read more » Full Article 340B Channel Management Gross-to-Net Bubble Hospitals Inflation Reduction Act of 2022 PBMs Pharmacy Specialty Drugs
act How the Perfect Storm Will Impact Patient Support Programming in 2025 and Beyond By feeds.feedblitz.com Published On :: Fri, 08 Nov 2024 05:23:00 +0000 Today’s guest post comes from Chris Dowd, Senior VP of Market Development at ConnectiveRx. Chris examines three key trends that will affect patient support programs: the Inflation Reduction Act (IRA), legal/regulatory battles over copay adjustment programs, and uncertainties following a national election. He then outlines three actions that should guide manufacturers' preparation. To learn more, register for ConnectiveRx’s free webinar on December 11: The Perfect Storm? Patient Support Programming in 2025 and Beyond. Read on for Chris’s insights. Read more » Full Article Guest Post Sponsored Post
act Bonus Episode: Fast Facts on the ACRO D&I Grants Program By mailchi.mp Published On :: Tue, 21 May 2024 10:13:00 +0000 ACRO’s Good Clinical Podcast is back with bonus episode! Host Sophia McLeod sat down with Tafoya Hubbard and Kristen Surdam to discuss ACRO’s new D&I Site Resource Grants Program. The post Bonus Episode: Fast Facts on the ACRO D&I Grants Program first appeared on ACRO. Full Article DEI News
act Sequestration Has Less Impact on FDA? Just Not True By www.fdamatters.com Published On :: Thu, 08 Aug 2013 20:11:21 +0000 “The Hill” newspaper recently reported that: “a survey of federal budgets devoted to developing and enforcing regulations found that many agencies will spend more in 2013 and 2014 than in previous years, indicating that the writing and enforcing of new regulations is largely unimpeded by the massive cuts, known as sequestration.” That certainly sounds authoritative…until you look at the analysis. In fact, the report’s authors appear to know nothing about the federal budget and have used inherently unreliable data in calculating FY 13 and FY 14 spending levels. One can only hope that the authors—allegedly academic experts--know more about regulatory policy than they do about federal budgets. Full Article FDA and Congress FDA and Industry FDA Appropriations
act Rhode Island Governor Vetoes Consumer Data Privacy Act By cohealthcom.org Published On :: Wed, 03 Jul 2024 14:32:46 +0000 On June 25th, Rhode Island Governor Daniel McKee transmitted without signature (effectively a pocket veto) the Rhode Island Data Transparency and Privacy Protection Act (SB 2500 / HB 7787). The act is based on the Washington Privacy Act model but diverges from the prevalent forms of that model in two ways. First, the act contains a unique […] Full Article Data Privacy Legislative consumer privacy data privacy legislation Rhode Island RI veto Washington Privacy Act
act ASBM/GaBI 2024 webinar on BIOSIMILAR RED TAPE ELIMINATION ACT (S2305) By www.gabionline.net Published On :: Tue, 05 Nov 2024 09:01:43 +0000 <p> <b>BIOSIMILAR RED TAPE ELIMINATION ACT (S2305):</b><br /> <b><i>Weakening FDA Regulatory Standards for Biosimilars, Undermining Physician Confidence and Jeopardizing Patient Health</i></b><br /><b>31 October 2024 | </b><b><a href="https://youtu.be/X6-dYZ7fjhM" target="_blank">WATCH REPLAY</a></b></p> Full Article
act The Biotech Startup Contraction Continues… And That’s A Good Thing By lifescivc.com Published On :: Fri, 26 Apr 2024 11:00:38 +0000 Venture creation in biotech is witnessing a sustained contraction. After the pandemic bubble’s over-indulgence, the venture ecosystem appears to have reset its pace of launching new startups. According to the latest Pitchbook data, venture creation in biotech hit its slowest The post The Biotech Startup Contraction Continues… And That’s A Good Thing appeared first on LifeSciVC. Full Article Biotech financing Biotech investment themes Capital markets Fundraising Biotech startups venture creation
act Waiver of Informed Consent - proposed changes in the 21st Century Cures Act By www.placebocontrol.com Published On :: Tue, 14 Jul 2015 20:21:00 +0000 Adam Feuerstein points out - and expresses considerable alarm over - an overlooked clause in the 21st Century Cures Act: Waive informed consent requirement for clinical trials?!?! Unbelievable but true if #Path2Cures becomes law. pic.twitter.com/dqmWPpxPdE — Adam Feuerstein (@adamfeuerstein) July 14, 2015 In another tweet, he suggests that the act will "decimate" informed consent in drug trials. Subsequent responses and retweets did nothing to clarify the situation, and if anything tended to spread, rather than address, Feuerstein's confusion. Below is a quick recap of the current regulatory context and a real-life example of where the new wording may be helpful. In short, though, I think it's safe to say: Waiving informed consent is not new; it's already permitted under current regs The standards for obtaining a waiver of consent are stringent They may, in fact, be too stringent in a small number of situations The act may, in fact, be helpful in those situations Feuerstein may, in fact, need to chill out a little bit (For the purposes of this discussion, I’m talking about drug trials, but I believe the device trial situation is parallel.) Section 505(i) - the section this act proposes to amend - instructs the Secretary of Health and Human Services to propagate rules regarding clinical research. Subsection 4 addresses informed consent: …the manufacturer, or the sponsor of the investigation, require[e] that experts using such drugs for investigational purposes certify to such manufacturer or sponsor that they will inform any human beings to whom such drugs, or any controls used in connection therewith, are being administered, or their representatives, that such drugs are being used for investigational purposes and will obtain the consent of such human beings or their representatives, except where it is not feasible or it is contrary to the best interests of such human beings. [emphasis mine] Note that this section already recognizes situations where informed consent may be waived for practical or ethical reasons. These rules were in fact promulgated under 45 CFR part 46, section 116. The relevant bit – as far as this conversation goes – regards circumstances under which informed consent might be fully or partially waived. Specifically, there are 4 criteria, all of which need to be met: (1) The research involves no more than minimal risk to the subjects; (2) The waiver or alteration will not adversely affect the rights and welfare of the subjects; (3) The research could not practicably be carried out without the waiver or alteration; and (4) Whenever appropriate, the subjects will be provided with additional pertinent information after participation. In practice, this is an especially difficult set of criteria to meet for most studies. Criterion (1) rules out most “conventional” clinical trials, because the hallmarks of those trials (use of an investigational medicine, randomization of treatment, blinding of treatment allocation) are all deemed to be more than “minimal risk”. That leaves observational studies – but even many of these cannot clear the bar of criterion (3). That word “practicably” is a doozy. Here’s an all-too-real example from recent personal experience. A drug manufacturer wants to understand physicians’ rationales for performing a certain procedure. It seems – but there is little hard data – that a lot of physicians do not strictly follow guidelines on when to perform the procedure. So we devise a study: whenever the procedure is performed, we ask the physician to complete a quick form categorizing why they made their decision. We also ask him or her to transcribe a few pieces of data from the patient chart. Even though the patients aren’t personally identifiable, the collection of medical data qualifies this as a clinical trial. It’s a minimal risk trial, definitely: the trial doesn’t dictate at all what the doctor should do, it just asks him or her to record what they did and why, and supply a bit of medical context for the decision. All told, we estimated 15 minutes of physician time to complete the form. The IRB monitoring the trial, however, denied our request for a waiver of informed consent, since it was “practicable” (not easy, but possible) to obtain informed consent from the patient. Informed consent – even with a slimmed-down form – was going to take a minimum of 30 minutes, so the length of the physician’s involvement tripled. In addition, many physicians opted out of the trial because they felt that the informed consent process added unnecessary anxiety and alarm for their patients, and provided no corresponding benefit. The end result was not surprising: the budget for the trial more than doubled, and enrollment was far below expectations. Which leads to two questions: 1. Did the informed consent appreciably help a single patient in the trial? Very arguably, no. Consenting to being “in” the trial made zero difference in the patients’ care, added time to their stay in the clinic, and possibly added to their anxiety. 2. Was less knowledge collected as a result? Absolutely, yes. The sponsor could have run two studies for the same cost. Instead, they ultimately reduced the power of the trial in order to cut losses. Bottom line, it appears that the modifications proposed in the 21st Century Cures Act really only targets trials like the one in the example. The language clearly retains criteria 1 and 2 of the current HHS regs, which are the most important from a patient safety perspective, but cuts down the “practicability” requirement, potentially permitting high quality studies to be run with less time and cost. Ultimately, it looks like a very small, but positive, change to the current rules. The rest of the act appears to be a mash-up of some very good and some very bad (or at least not fully thought out) ideas. However, this clause should not be cause for alarm. Full Article 21st Century Cures Act Adam Feuerstein informed consent
act Hospitals face months of IV fluid shortages after Helene damages N.C. factory By www.npr.org Published On :: Sun, 10 Nov 2024 08:34:20 -0500 Hospitals have been forced to innovate with new ways of hydrating patients and giving them medications, after a key factory that produces IV fluid bags flooded during Hurricane Helene. (This story first aired on Morning Edition on Nov. 7, 2024.) Full Article
act What does a 2nd Trump term mean for the Affordable Care Act? By www.npr.org Published On :: Mon, 11 Nov 2024 04:47:01 -0500 President-elect Donald Trump tried unsuccessfully to get rid of the Affordable Care Act during his first term. What action will he take this time around? Full Article
act How Did Attendees at a Behavioral Health Conference React to Trump’s Victory? By medcitynews.com Published On :: Thu, 07 Nov 2024 04:08:38 +0000 When it comes to the effects that the upcoming Trump presidency will have on healthcare, attendees’ attitudes ranged from cautiously optimistic to fairly anxious. Some of the issues they highlighted included mental health parity, telehealth prescribing flexibilities, and the role of Robert F. Kennedy Jr. The post How Did Attendees at a Behavioral Health Conference React to Trump’s Victory? appeared first on MedCity News. Full Article Health Tech Pharma Providers Behavioral Health Tech election 2024 Mental Health parity telehealth Trump Trump administration
act Measuring Impact in Digital Youth Mental Health: What Investors Look For By medcitynews.com Published On :: Fri, 08 Nov 2024 20:02:39 +0000 Many companies are entering the digital youth mental health space, but it’s important to know which ones are effective, according to a panel of investors at the Behavioral Health Tech conference. The post Measuring Impact in Digital Youth Mental Health: What Investors Look For appeared first on MedCity News. Full Article Health Tech SYN Top Story Behavioral Health Tech digital health outcomes youth mental health
act Pew Applauds Michigan for Enacting Bipartisan Legislation to Safely Reduce Jail Populations By www.pewtrusts.org Published On :: Thu, 14 Jan 2021 15:00:29 -0500 The Pew Charitable Trusts today commended Michigan Governor Gretchen Whitmer (D), state Senate Majority Leader Mike Shirkey (R), and Lee Chatfield (R)—whose term as state House Speaker ended last month—for passing and signing a bipartisan package of bills aimed at protecting public safety while reducing the number of people in county jails. Full Article
act Tools to Boost Beneficial Bacteria Can Help Poultry Farms Fight Salmonella By www.pewtrusts.org Published On :: Mon, 25 Jan 2021 09:13:00 -0500 Chicken products cause an estimated 1 in 7 of the nation’s human Salmonella illnesses each year, partly because the pathogen can easily contaminate the environments where birds are raised. To reduce the risk that contaminated meat will reach consumers, poultry companies need measures that control the bacterium on farms where chickens are bred and raised. Full Article
act Standard Technology Presents Opportunities for Medical Record Data Extraction By www.pewtrusts.org Published On :: Tue, 26 Jan 2021 10:38:00 -0500 Technology has revolutionized the way people live their lives. Individuals can use smartphones to access their bank account, shop from almost any store, and connect with friends and family around the globe. In fact, these personal devices have tethered communities together during the coronavirus pandemic, allowing many people to maintain much of their lives remotely. Full Article
act En Banc: Federal Circuit Provides Guidance on Application of On-Sale Bar to Contract Manufacturers By www.lifescienceslawblog.com Published On :: Fri, 15 Jul 2016 16:04:54 +0000 Pharmaceutical and biotech companies breathed a sigh of relief Monday when the Federal Circuit unanimously ruled in a precedential opinion that the mere sale of manufacturing services to create embodiments of a patented product is not a “commercial sale” of the invention that triggers the on-sale bar of 35 U.S.C. § 102(b) (pre-AIA).[1] The en banc opinion...… Continue Reading Full Article Intellectual Property Ben Venue Laboratories CMO MedCo On-Sale Bar
act Impact of Trump and Harris on Prescription Drug Pricing By worldofdtcmarketing.com Published On :: Thu, 31 Oct 2024 12:16:02 +0000 The upcoming U.S. presidential election is stirring discussions around healthcare, especially the cost of prescription drugs and the […] The post Impact of Trump and Harris on Prescription Drug Pricing appeared first on World of DTC Marketing. Full Article As I See It Business of the drug industry Cost of healthcare in the U.S. in the news Election & Pharma
act Jardiance DTC Ads: Consumer Reactions on Social Media By worldofdtcmarketing.com Published On :: Sat, 02 Nov 2024 14:03:45 +0000 Jardiance is a popular drug used to treat type 2 diabetes and help reduce cardiovascular risk. DTC campaigns […] The post Jardiance DTC Ads: Consumer Reactions on Social Media appeared first on World of DTC Marketing. Full Article Focus on patients DTC DTC Ads Jardiance
act Impact of Trump on Drug Pricing Policies By worldofdtcmarketing.com Published On :: Wed, 06 Nov 2024 10:14:23 +0000 With Trump’s victory, healthcare and the pharmaceutical industry could shift significantly. Based on Trump’s first-term policies, his administration […] The post Impact of Trump on Drug Pricing Policies appeared first on World of DTC Marketing. Full Article in the news Changes in healthcare
act South Korean actor Song Jae-rim dies aged 39, celebrities pay tribute By www.asiaone.com Published On :: Wed, 13 Nov 2024 13:20:14 +0800 South Korean actor Song Jae-rim died yesterday (Nov 12) at the age of 39. The Seongdong Police Station in Seoul confirmed that he was found deceased in his apartment at around 12.30pm. According to media reports, a friend whom he was supposed to meet for lunch had visited his home and reported the death. A two-page letter was reportedly found at the scene but the cause of death has not been confirmed. A police official, however, stated that there are "no signs of foul play". His wake was held at Yeouido St. Mary’s Hospital Funeral Hall at 5.30pm yesterday. His funeral will be held tomorrow at Seoul City Crematorium. Jae-rim gained popularity after starring in the 2012 drama The Moon Embracing the Sun and the 2014 reality series We Got Married. This year, he starred in two dramas — My Military Valentine and Queen Woo. Following news of his death, comedian Hong Seok-cheon and other celebrities posted tributes to Jae-rim on social media. Full Article
act Police probing deepfake nude photos of Singapore Sports School students; school meting out disciplinary actions By www.asiaone.com Published On :: Tue, 12 Nov 2024 16:55:49 +0800 SINGAPORE – The police are investigating deepfake nude photos of Singapore Sports School (SSP) students that were created and spread by other students. In response to queries from The Straits Times, school principal Ong Kim Soon said SSP is “aware of the incident involving the creation and sharing of deepfake photos by our student-athletes”. “The school does not condone such harmful behaviour,” he said, adding that it has launched an investigation and lodged a police report. The police, in response to queries from ST, confirmed that a report was lodged and investigations are ongoing. A reader who identified himself as a parent of a victim had alerted ST in an e-mail on Nov 12 about the deepfake nude images that were being circulated. “Many parents of affected female students in Singapore Sports School are making police reports about deepfake nude photos of their daughters generated by male students from the school,” the parent said. When contacted, the parent said that female teachers were also targeted, and that the school has offered affected students counselling. Full Article
act Pakistan limits outdoor activities, market hours to curb air pollution-related illness By www.asiaone.com Published On :: Tue, 12 Nov 2024 10:21:25 +0800 LAHORE — Pakistan's Punjab province banned most outdoor activities and ordered shops, markets and malls in some areas to close early from Monday (Nov 11) to curb illnesses caused by intense air pollution. The province has closed educational institutions and public spaces like parks and zoos until Nov. 17 in places including Lahore, the world's most polluted city in terms of air quality, according to Swiss group IQAir's live ratings. The districts of Lahore, Multan, Faisalabad and Gujranwala have seen an unprecedented rise in patients with respiratory diseases, eye and throat irritation, and pink eye disease, the Punjab government said in an order issued late on Sunday. The new restrictions will also remain in force until Nov. 17. "The spread of conjunctivitis/ pink eye disease due to bacterial or viral infection, smoke, dust or chemical exposure is posing a serious and imminent threat to public health," the Punjab government said. Full Article
act South Korea's Yoon practices golf to prepare for future Trump meets By www.asiaone.com Published On :: Tue, 12 Nov 2024 12:58:31 +0800 SEOUL — South Korean President Yoon Suk-yeol recently began practising golf, for the first time in eight years, in preparation for future meetings with US President-elect Donald Trump, Yoon's office confirmed on Tuesday (Nov 12). South Korean media said Yoon visited a golf course on Saturday for a sport his office said he had last played in 2016. "A lot of people close to President Trump... (told me) President Yoon and Trump will have good chemistry," Yoon told a press conference on Thursday, after congratulating Trump by telephone on his win. Former Trump administration officials and influential Republicans had offered to help build ties with the incoming president, he added. Analysts said Yoon may seek to find a way to capitalise on a personal friendship with Trump to advance Seoul's interests as Trump's "America First" foreign policy plans and his unpredictable style play out in his second term. South Korean companies rely heavily on trade with the United States, and during Trump's first term, the countries clashed over cost-sharing for the roughly 28,500 US troops stationed in South Korea as a legacy of the 1950-1953 Korean War. Full Article
act Noel Kempff Mercado Climate Action Project: The Promise and Peril of High-Potential Environmental Partnerships By www.belfercenter.org Published On :: Feb 9, 2023 Feb 9, 2023 In the first comprehensive post-mortem analysis of the Noel Kempff Mercado Climate Action Project (NKMCAP), Reine Rambert and Amanda Sardonis examine how NKMCAP failed to live up to its potential, by focusing on three different dimensions of partnership effectiveness: 1) the sustainability of the partnership, 2) the effectiveness of the collaboration process itself, and 3) the achievement of the planned objectives. Rambert and Sardonis extract several transferable lessons from the challenges faced by NKMCAP that are highly consequential to partnership effectiveness. Full Article
act ‘We have some contacts with bad guys and perhaps one of them did it' By www.thehindu.com Published On :: Thu, 19 May 2011 23:14:06 +0530 Pakistan's National Security Adviser to the Prime Minister, Mahmud Ali Durrani, on the 2008 bombing of the Indian Embassy in Kabul Full Article News
act ‘Pakistan's actions at the UN may embolden other member states to oppose U.S. positions' By www.thehindu.com Published On :: Tue, 24 May 2011 05:04:02 +0530 U.S. Mission in New York raised concerns about Pakistan's voting on key issues such as counterterrorism and human rights Full Article Comment
act 242073: Action request for senior level engagement on terrorism finance By www.thehindu.com Published On :: Tue, 31 May 2011 01:42:05 +0530 Cutting off the flow of funds to terrorist organizations and achieving stability in Af/Pak are top U.S. priorities. Full Article The Cables
act 6 Months On: What is the Impact of the War in Gaza? By www.belfercenter.org Published On :: Apr 5, 2024 Apr 5, 2024 6 months on: What is the impact of the war in Gaza?Brookings experts reflect on the conflict Full Article
act The impact of Iran’s attack on Israel By www.belfercenter.org Published On :: Apr 15, 2024 Apr 15, 2024 Brookings scholars offer their insights following Iran’s drone and missile attack against Israel on April 13, 2024. Their responses provide perspectives on the implications for various actors as well as a range of policy issues. Full Article
act Europe gas market shows muted reaction to US Trump win By www.argusmedia.com Published On :: 06 Nov 2024 17:27 GMT Full Article Natural gas Pipeline LNG Europe North America Fundamentals Politics
act EU minor metal markets await US reaction to Trump win By www.argusmedia.com Published On :: 07 Nov 2024 15:11 GMT Full Article Metals Non-ferrous Minor metals Chromium Tantalum Tungsten Europe Global US
act Austria to ask EU to act if German gas levy not removed By www.argusmedia.com Published On :: 08 Nov 2024 17:41 GMT Full Article Natural gas Czech Republic Austria Germany Pipeline Tariffs Regulation Taxation and royalties Energy policy Grid
act Fact extends NPK/NPS buy tenders By www.argusmedia.com Published On :: 11 Nov 2024 11:45 GMT Full Article NPK Global India Demand
act We All Fall Down: The Dismantling of the Warsaw Pact and the End of the Cold War in Eastern Europe By www.belfercenter.org Published On :: Mar 14, 2024 Mar 14, 2024 The non-Soviet members of the Warsaw Pact contributed to the end of the Cold War along with the superpowers. These Eastern European states recognized that their relationship with the Soviet Union would impede their success in the post–Cold War world, so they ended the Pact. Full Article
act Nobody Actually Knows What Russia Does Next By www.belfercenter.org Published On :: Apr 2, 2024 Apr 2, 2024 Stephen Walt argues that because no one knows what Putin might do, NATO's European members should increase their defense capabilities and correct any obvious vulnerabilities. At the same time, however, the United States and its NATO allies should acknowledge Russia's legitimate security concerns and consider what they can do to allay them. Full Article
act Event Debrief: Why the Inflation Reduction Act Passed By www.belfercenter.org Published On :: Jun 5, 2024 Jun 5, 2024 Harvard Kennedy School hosted Leah Stokes, Anton Conk Associate Professor of Environmental Politics at UC Santa Barbara, to discuss how the historic Inflation Reduction Act succeeded where so many previous climate bills failed. Full Article
act Democratic Transitions and Conflict Zones: The Impact on Policy-Making in Africa By www.belfercenter.org Published On :: Mar 28, 2024 Mar 28, 2024 On March 26, the study group met for the first time to examine recent democratic progress and backsliding in African countries. The session focused on ongoing conflicts in different regions of Africa and examined their political underpinnings. Participants also discussed the role of third-party actors in supporting and facilitating conflict mediation and peacebuilding efforts in the continent. The study group counted with the presence of external expert guest Dr. Antje Herrberg, Chief of Staff of the European Union Capacity Building Mission in Niger (EUCAP Sahel Niger). Dr. Herrberg brings more than two decades of professional and personal experience in transition and conflict resolution, intractable conflict, and terrorism with a deep interest to alleviate the suffering of people. Furthermore, Florian Dirmayer, Master in Public Policy Candidate at Harvard Kennedy School, delivered a memo briefing on European Union Security Cooperation with Niger After the 2023 Military Coup. Full Article
act Strategic Myopia: The Proposed First Use of Tactical Nuclear Weapons to Defend Taiwan By www.belfercenter.org Published On :: Mar 14, 2024 Mar 14, 2024 David Kearn argues that the idea that the first use of nuclear weapons since 1945 would be by the United States in the defense of Taiwan against a conventional Chinese invasion would have significant, negative, and long-lasting, diplomatic ramifications. It is difficult to fathom the myriad potential consequences, but U.S. nuclear weapon use would almost certainly shatter the non-proliferation regime as a functioning entity, incentivize states (including China) to acquire or improve their existing nuclear arsenal, and damage America's standing globally. Full Article
act Russia's Invasion of Ukraine and Its Impact on the Global Nuclear Order By www.belfercenter.org Published On :: Apr 17, 2024 Apr 17, 2024 Mariana Budjeryn presents "Russia's Invasion of Ukraine and Its Impact on the Global Nuclear Order" at the DOE/NNSA Administrator's Strategy Forum Full Article
act When Actions Speak Louder Than Words: Adversary Perceptions of Nuclear No-First-Use Pledges By www.belfercenter.org Published On :: Jun 4, 2024 Jun 4, 2024 Would the world be safer if the United States pledged to never use nuclear weapons first? Supporters say a credible pledge would strengthen crisis stability, decrease hostility, and bolster nonproliferation and arms control. But reactions to no-first-use pledges by the Soviet Union, China, and India suggest that adversaries perceive pledges as credible only when the political relationship between a state and its adversary is already relatively benign, or when the state’s military has no ability to engage in nuclear first use against the adversary. Full Article
act Impacts of Electric Vehicle Subsidies: A Conversation with Hunt Allcott By www.belfercenter.org Published On :: Apr 8, 2024 Apr 8, 2024 Behavioral economist Hunt Allcott, Professor of Global Environmental Policy at the Doerr School of Sustainability at Stanford University, questioned the impact of new and used electric vehicle (EV) subsidies in the latest episode of “Environmental Insights: Discussions on Policy and Practice from the Harvard Environmental Economics Program.” Full Article
act Leveraging Charging Strategies to Reduce Grid Impacts of Electric Vehicles By www.belfercenter.org Published On :: May 8, 2024 May 8, 2024 Electric vehicles (EVs) can challenge or support electricity systems depending on how they are charged. Controlled charging that combines technical solutions with heterogenous EV user behaviors can reduce peak demand to avoid grid constraints and support the integration of renewable energy. Full Article
act Harvard Project Director Robert Stavins Moderates Climate Action Week Panel on “Strategies for Mitigating Global Methane Emissions” By www.belfercenter.org Published On :: Jul 11, 2024 Jul 11, 2024 Efforts to measure and mitigate the impact of methane emissions was the topic of discussion last Monday (June 10, 2024) at a panel convened as part of Climate Action Week in the Northwest Building, sponsored by Harvard’s Salata Institute for Climate and Sustainability and moderated by Harvard Environmental Economics Program and Harvard Project Director Robert Stavins. Full Article
act Former Residents of Huronia, Rideau, and Southwestern Regional Centres Could Receive Compensation from Class Action Settlements - Settlement Overview Video By www.multivu.com Published On :: 24 Apr 2014 16:12:00 EDT Settlement Overview Video. If you lived at Huronia, Rideau, or Southwestern Regional Centres, you may be eligible to make a claim. Full Article Banking Financial Services Legal Issues Broadcast Feed Announcements MultiVu Video
act Survey Finds Gap Between Home Protection Concerns And Consumer Actions - Kristin Chenoweth Protect It Or Lose It Video By www.multivu.com Published On :: 22 Jul 2014 16:23:00 EDT Kristin Chenoweth teamed up with Allstate to quiz homeowners on the value of the possessions in their home - see what they know, and don't know! Full Article Auto Banking Financial Services Household Consumer Cosmetics Insurance Multimedia Online Internet Broadcast Feed Announcements Survey Polls & Research MultiVu Video
act Closing "Strategy-to-Execution Gaps" Key Factor for Companies to Achieve Growth Targets - Growth Unlocked: Closing the Strategy-to-Execution Gap By www.multivu.com Published On :: 09 Dec 2014 20:15:00 EST Growth Unlocked: Closing the Strategy-to-Execution Gap Full Article Banking Financial Services Workforce Management Human Resources Broadcast Feed Announcements MultiVu Video